Troy, NY, United States of America

John Quinn

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.3

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

**Title: John Quinn: Innovator in Pharmaceutical Formulations**

Introduction

John Quinn is a notable inventor based in Troy, NY, who has made significant contributions to the field of pharmaceuticals. With three patents to his name, his work focuses primarily on storage stable formulations of sulfated glycosaminoglycans, which are crucial for the treatment of pain and various medical conditions. His innovations are paving the way for advancements in pharmaceutical compositions and medical therapies.

Latest Patents

One of John Quinn's latest patents involves storage stable pharmaceutical compositions comprising a sulfated glycosaminoglycan with an average molecular weight ranging from 3,000 to 15,000 Daltons. This invention also includes a pharmaceutical carrier that is blended with the sulfated glycosaminoglycan, aimed at enhancing the treatment for conditions requiring medical intervention. Another significant aspect of this patent is the method of using this composition to achieve a medically observable improvement in patients. Additionally, the patent outlines a process for producing a purified, storage stable sulfated glycosaminoglycan, indicating the depth of research and innovation involved in his work.

Career Highlights

John Quinn is currently associated with Adora Animal Health Corporation, where he continues to advance his research and development efforts. His dedication to innovation and the application of his patents has positioned him as a key player in the pharmaceutical industry.

Collaborations

Throughout his career, John has collaborated with esteemed colleagues, including Thomas Michael Vaughn and David J. Fairfax. Their collective efforts contribute to the innovative advancements being made in the formulations they develop, highlighting the importance of teamwork in the invention process.

Conclusion

In summary, John Quinn is an influential inventor whose work on storage stable formulations of sulfated glycosaminoglycans has the potential to address significant medical needs. His patents and collaborations reflect a commitment to improving health outcomes, proving that innovation in pharmaceuticals can lead to substantial advancements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…